Human Immunodeficiency Virus Type 1 Protease Inhibitors Block Toll-Like Receptor 2 (TLR2)- and TLR4-Induced NF-κB Activation

  • Ozlem Equils, Alan Shapiro, Zeynep Madak, Chunren Liu, Daning Lu
  • Antimicrobial Agents and Chemotherapy, October 2004, ASM Journals
  • DOI: 10.1128/aac.48.10.3905-3911.2004

The authors haven't yet claimed this publication.

Read Publication

http://dx.doi.org/10.1128/aac.48.10.3905-3911.2004